| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/24/2008 | US20080020393 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease |
| 01/24/2008 | US20080020383 Haplotype Markers And Methods Of Using The Same To Determine Response To Treatment |
| 01/24/2008 | US20080020377 Peptide-Based Method for Monitorting Gene Expression in a Host Cell |
| 01/24/2008 | US20080020371 Reverse Genetics System |
| 01/24/2008 | US20080020063 Anti-angiogenic compositions and methods of use |
| 01/24/2008 | US20080020001 Preparation of protective antigen |
| 01/24/2008 | US20080019994 Immunization Against Chlamydia Infection |
| 01/24/2008 | US20080019991 Carrier Conjugates Of Tnf-Peptides |
| 01/24/2008 | US20080019988 Targeting of genetic vaccine vectors |
| 01/24/2008 | US20080019987 using a composition comprising a multimeric galectin-1 polypeptide to decrease inflammation of a tissue |
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | US20080019985 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080019976 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo |
| 01/24/2008 | US20080019971 36P6D5: secreted tumor antigen |
| 01/24/2008 | US20080019968 Detection, prevention and treatment of breast cancer |
| 01/24/2008 | US20080019967 Inflammatory mediator antagonists |
| 01/24/2008 | US20080019960 Use of alefacept aka AMVIVE (reg) to treat herpes, HIV, hepatitis, papillomavirus, Epstein-Barr virus, cytomegalovirus in humans; includes co-infected individuals |
| 01/24/2008 | US20080019940 Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
| 01/24/2008 | US20080019914 Pesticidally Active Proteins and Polynucleotides Obtainable from Paenibacillus Species |
| 01/24/2008 | US20080019912 Glycoprotein 5 (GP5) and M protein of PRRSV linked by a disulfide bond gives rise to protective antigenic determinant (PAD polypeptide) that is used provide protection PRRSV; immunizing pigs |
| 01/24/2008 | US20080019908 Novel amphiphilic substance, and drug delivery system and molecular imaging system using the same |
| 01/24/2008 | DE19726167B4 Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung Insulin, to processes for its preparation and pharmaceutical preparation containing |
| 01/24/2008 | CA2829865A1 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 01/24/2008 | CA2658683A1 Positive cytomodulines to improve bioreactor productivity |
| 01/24/2008 | CA2658677A1 Novel bacillus thuringiensis gene with lepidopteran activity |
| 01/24/2008 | CA2658633A1 Chiral compounds substituted with phosphonic acid ester functions or phosphonic acid functions |
| 01/24/2008 | CA2658596A1 Method for screening an enhancer or a masker of salty taste |
| 01/24/2008 | CA2658582A1 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 01/24/2008 | CA2658576A1 Novel bacillus thuringiensis gene with lepidopteran activity |
| 01/24/2008 | CA2658286A1 Human glp-1 mimetibodies, compositions, methods and uses |
| 01/24/2008 | CA2658273A1 Process for producing arachidonic acid and/or eicosapentaenoic acid in plants |
| 01/24/2008 | CA2658265A1 Amigo-2 inhibitors for treating, diagnosing or detecting cancer |
| 01/24/2008 | CA2657934A1 Wsx-1/p28 as a target for anti-inflammatory responses |
| 01/24/2008 | CA2657819A1 Whole blood-derived coagulum device for treating bone defects |
| 01/24/2008 | CA2657349A1 Human growth and differentiation factor gdf-5 |
| 01/24/2008 | CA2630857A1 Fsh mutants |
| 01/23/2008 | EP1881327A2 Diagnosis and treatment of malignant neoplasms |
| 01/23/2008 | EP1881323A1 Method of stabilizing pulmonary surfactant protein |
| 01/23/2008 | EP1881075A1 Retroviral vectors having a reduced recombination rate |
| 01/23/2008 | EP1881074A2 Transgenic plants with increased glycine-betaine |
| 01/23/2008 | EP1881073A2 Phosphatase stress-related protein and methods of use in plants |
| 01/23/2008 | EP1881072A1 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initation factor 5A, transgenic plants and a method for controlling senescene and programmed cell death in plants |
| 01/23/2008 | EP1881071A1 Methods and materials relating to gene expression |
| 01/23/2008 | EP1881070A2 Human cytokine as ligand of the zalpha receptor and uses thereof |
| 01/23/2008 | EP1881069A1 Transforming growth factor alpha HII |
| 01/23/2008 | EP1881065A1 DINO polypetide |
| 01/23/2008 | EP1881064A2 HCV-Anti-core monoclonal antibodies |
| 01/23/2008 | EP1881007A1 LLR-J24 related proteins |
| 01/23/2008 | EP1881006A1 Parathyroid hormone analogues for the treatment of osteoporosis |
| 01/23/2008 | EP1881005A1 Derivatives of growth hormone and related proteins |
| 01/23/2008 | EP1881004A1 Novel collectin |
| 01/23/2008 | EP1880735A2 Vaccine |
| 01/23/2008 | EP1880731A1 Human growth and differentiation factor GDF-5 |
| 01/23/2008 | EP1880728A1 Peptide having anti-anxiety effect and method for screening thereof |
| 01/23/2008 | EP1880207A2 Competitive particle immunoassay methods utilizing fluorescence microscopy |
| 01/23/2008 | EP1880012A1 Vaccine composition |
| 01/23/2008 | EP1880005A2 Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions |
| 01/23/2008 | EP1879919A2 Polypeptide, vaccine and use thereof |
| 01/23/2008 | EP1879918A1 Method of producing a set of mhc molecules |
| 01/23/2008 | EP1879917A2 Nogo receptor functional motifs and peptide mimetics related thereto and methods of using the same |
| 01/23/2008 | EP1879916A1 Acute leukemia and lymphoblastic lymphoma-specific cd43 epitope and use thereof |
| 01/23/2008 | EP1879915A1 Gene encoding glycogen synthesis initiator and use thereof |
| 01/23/2008 | EP1879914A2 Ehrlichia canis diva (differentiate infected from vaccinated animals) |
| 01/23/2008 | EP1879913A1 Axmi-028 and axmi-029, family of novel delta-endotoxin genes and methods for their use |
| 01/23/2008 | EP1879912A1 Novel assay for the separation and quantification of hemagglutinin antigens |
| 01/23/2008 | EP1879604A2 Pif tetrapeptides |
| 01/23/2008 | EP1622635A4 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 01/23/2008 | EP1620554B1 Recombinant fel d 1 allergen |
| 01/23/2008 | EP1578452B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 01/23/2008 | EP1576135A4 Method for regulating dopamine producing cells |
| 01/23/2008 | EP1572679A4 Crfr1 selective ligands |
| 01/23/2008 | EP1549339A4 Targeting of herpes simplex virus to specific receptors |
| 01/23/2008 | EP1534064A4 Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements |
| 01/23/2008 | EP1527097B1 Method for purifying preproinsulin |
| 01/23/2008 | EP1446478B1 Dimerized growth factor and materials and methods for producing it |
| 01/23/2008 | EP1436316B1 Subcellular targeting of therapeutic proteins |
| 01/23/2008 | EP1401267A4 Animal model for allergy |
| 01/23/2008 | EP1366175B1 Multifunctional protease inhibitors and their use in treatment of disease |
| 01/23/2008 | EP1272514B1 Dna encoding human vanilloid receptor vr3 |
| 01/23/2008 | EP1240332B1 Streptococcus pyogenes virulence genes and proteins and their use |
| 01/23/2008 | EP1240310B1 Method of inactivating microorganisms |
| 01/23/2008 | EP1220925B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1210372B1 Human monoclonal antibodies to her2/neu |
| 01/23/2008 | EP1194445B1 Methods for purifying recombinant growth hormone antagonist proteins using aqueous two-phase extraction |
| 01/23/2008 | EP1175444B1 Amino-terminal modified parathyroid hormone (pth) analogs |
| 01/23/2008 | EP1141315B1 Modified hiv env polypeptides |
| 01/23/2008 | EP1140998B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | CN101111599A Expression carrier used for treating bacterial infection |
| 01/23/2008 | CN101111595A Method of constructing novel higher plant and mehtod of promoting the growth of higher plant |
| 01/23/2008 | CN101111523A Process for producing natural immunobiotic extract and uses thereof |
| 01/23/2008 | CN101111520A Mhc oligomer and method of making the same |
| 01/23/2008 | CN101111519A Human interferon-beta mutein |
| 01/23/2008 | CN101111518A Motif of beclin protein which interacts with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 01/23/2008 | CN101111517A Novel peptides which interact with anti-apoptotic members ofthe family of bcl-2 proteins and use thereof |
| 01/23/2008 | CN101111516A Conjugates of biologically active proteins having a modified in vivo half-life |
| 01/23/2008 | CN101111515A Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 01/23/2008 | CN101111514A Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response |
| 01/23/2008 | CN101111511A Process for protein isolation |
| 01/23/2008 | CN101111260A Survivin peptide vaccine |
| 01/23/2008 | CN101111227A Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |